The current study was approved by the Tianjin Medical University Medical Ethics Committee and done in accordance with the Declaration of Helsinki; current revisions and experiments were carried out in accordance with the approved guidelines. The hUCMSCs (Tianjin Saier Biological Company, TEDA, Tianjin, China) were incubated in six-well plates and cultured for 48 hours. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 (Sigma-Aldrich Corp., St. Louis, MO, USA) containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37°C in humidified atmosphere with 5% CO2. Then, the cells were seeded with antibodies against FITC-CD105, FITC-CD73, FITC-CD29, FITC-CD90, FITC-CD31, FITC-CD44, FITC-CD34, FITC-CD45, and PE-HLA-DR for 30 minutes at 37°C. After digestion with trypsin and centrifugation, the cells were collected and washed twice with PBS. The cells were preblocked with 5% bovine serum albumin for 30 minutes and incubated overnight with antibody at 4°C. Fluorescence was examined by flow cytometry (BD FACSAris; Beckman-Dickinson, San Jose, CA, USA). The dermal fibroblasts (Tianjin Saier Biological) were incubated in DMEM (Beyotime, Nantong, China) containing 100 U/ml penicillin, 10% fetal bovine serum, and 100 μg/ml streptomycin under conditions of 5% CO2 and 37°C.
Exosome isolation was performed according to a previously published protocol.
21 Briefly, hUCMSCs or dermal fibroblasts (passage 3–5) were cultured in FBS-free medium; the supernatant was then centrifuged (CP100WX/CR22N, HITACHI) at 4°C sequentially for 10 minutes at 300
g, 20 minutes at 2000
g, and 30 minutes at 10,000
g. After each centrifugation step, the pellet was removed and discarded. Exosomes were then precipitated by ultracentrifugation of the supernatant (70 minutes at 100,000
g). The pellet was resuspended in PBS after washing twice. The exosome preparation was passed through a 0.22 μm filter and stored at −20°C until use. The size distribution of exosomes was measured using a nanoparticle tracking and NanoSight analysis system (NS300; Malvern Instruments, Malvern, UK). The morphology of the exosomes was characterized by transmission electron microscopy. The surface markers of the exosomes were examined by Western blotting analysis. Total protein from exosomes was extracted in lysis buffer, and protein concentrations were measured with a protein BCA assay kit. Samples were boiled at 95°C for 5 minutes and loaded onto a sodium dodecyl sulfate polyacrylamide gel for electrophoresis, then transferred to a PVDF membrane. The primary antibodies included antibodies to CD63 (Invitrogen, Carlsbad, CA, USA), CD9 (Invitrogen), CD81 (Invitrogen), and GADPH (Invitrogen). The membranes were blocked with 5% nonfat dried milk and incubated in the primary antibodies overnight at 4°C. The membranes were incubated with secondary antibodies for 2 hours.